MicroRNA as a marker for kidney cancer

A recent study has provided evidence that a group of microRNAs, called the miRNA-200 family, can be used to predict the likely course of clear cell renal cell carcinoma (RCC). MicroRNAs (miRNAs) are small pieces of RNA (nucleic acid that is found in all living cells) that act as messengers to regulate the synthesis of […]

read more

Potential prognostic marker for kidney cancer

A recent study to be published in Clinical and Experimental Medicine next month investigates the role of microRNAs (miRNAs) in the development of renal cell carcinoma (RCC) and the levels of miRNA-15a in RCC tumours. The investigators showed that increased miRNA-15a was associated with indicators of poor prognosis, such as high Fuhrman grade, the presence […]

read more

Potential prognostic biomarker for clear cell RCC

A recent study published in Oncology Letters last month has identified a microRNA as a potential biomarker for the outcome of patients with clear cell renal cell carcinoma (RCC). MicroRNA is genetic material found in cells that regulates the expression of genes. The aim of the study was to look at three microRNAs that could […]

read more

MicroRNA as a potential biomarker for kidney cancer

Recently, researchers are focusing on microRNAs (miRNAs) circulating in the bloodstream as potential biomarkers for the detection and diagnosis of clear cell renal cell carcinoma (ccRCC). miRNA may also be used as a targeted therapy for ccRCC. “We know what genes are responsible for RCC, or at least many cases of RCC,” said Farhad R. […]

read more
Showing all 4 results
  TOP